Mwanzo069620 • KRX
add
Daewoong Pharma
Bei iliyotangulia
₩ 169,800.00
Bei za siku
₩ 157,800.00 - ₩ 164,900.00
Bei za mwaka
₩ 109,000.00 - ₩ 199,400.00
Thamani ya kampuni katika soko
1.88T KRW
Wastani wa hisa zilizouzwa
elfu 38.50
Uwiano wa bei na mapato
20.02
Mgao wa faida
0.37%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 411.83B | 14.88% |
Matumizi ya uendeshaji wa biashara | 156.83B | 8.36% |
Mapato halisi | 46.37B | 63.95% |
Kiwango cha faida halisi | 11.26 | 42.71% |
Mapato kwa kila hisa | — | — |
EBITDA | 69.45B | 41.15% |
Asilimia ya kodi ya mapato | 13.56% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 208.62B | 94.04% |
Jumla ya mali | 2.26T | 17.58% |
Jumla ya dhima | 1.22T | 25.77% |
Jumla ya hisa | 1.04T | — |
hisa zilizosalia | 11.51M | — |
Uwiano wa bei na thamani | 2.22 | — |
Faida inayotokana na mali | 6.51% | — |
Faida inayotokana mtaji | 8.00% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 46.37B | 63.95% |
Pesa kutokana na shughuli | 57.53B | 159.07% |
Pesa kutokana na uwekezaji | -73.82B | -42.84% |
Pesa kutokana na ufadhili | 57.48B | 57.12% |
Mabadiliko halisi ya pesa taslimu | 44.69B | 548.42% |
Mtiririko huru wa pesa | -12.48B | 64.80% |
Kuhusu
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1945
Tovuti
Wafanyakazi
1,644
